CARL WILSON: Open Payments
NPI 1386147957 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 28 payments from 7 companies in 2025. Trend: 2023 $159 · 2024 $303 · 2025 $656
Food & beverage: $603Education: $53
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $237 |
| GENZYME CORPORATION | 12 | $216 |
| GlaxoSmithKline, LLC. | 3 | $65 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Amgen Inc. | 2 | $39 |
| Optinose US, Inc. | 1 | $28 |
| Stryker Corporation | 1 | $19 |
Products named: DUPIXENT, NUCALA, LIBTAYO, Xhance, TEZSPIRE, CLARIFIX.
Industry payments across AZ — which companies pay providers there.
